Skip to main content

Sartorius Ad


  • Monday, Feb 5th
    10:00 AM – 12:00 PM EST
    Vascularized In Vitro Cellular Models
    Room/Location:  210A
    Cellular Technologies (Room 210A)
  • Monday, Feb 5th
    10:00 AM – 10:30 AM EST
    Functional immune phenotyping of sepsis patients using organ-on-chip
    Room/Location:  210A
    Laurie Kilpatrick, PhD (she/her/hers) – Temple University School of Medicine
    Cellular Technologies (Room 210A)
  • Monday, Feb 5th
    10:30 AM – 11:00 AM EST
    3D-Bioprinted Vascularized Eye Tissue Provides a Patient-Specific Model to Test Therapies for Inherited and Age-Related Macular Degenerations
    Room/Location:  210A
    Cellular Technologies (Room 210A)
  • Monday, Feb 5th
    11:00 AM – 11:30 AM EST
    Application of Blood-Brain-Barrier-on-Chip models for assessing antibody transcytosis and CAR-T mediated neurotoxicity
    Room/Location:  210A
    Anna Jezierski, PhD (she/her/hers) – National Research Council of Canada
    Cellular Technologies (Room 210A)
  • Monday, Feb 5th
    11:30 AM – 12:00 PM EST
    A Novel Microfluidic Device for Modeling an Artery-on-a-Chip and Cardiovascular Diseases
    Room/Location:  210A
    Bas Trietsch – PhD
    Cellular Technologies (Room 210A)
  • Monday, Feb 5th
    3:00 PM – 5:00 PM EST
    Immunocompetent Cellular Systems for Disease Modeling
    Room/Location:  210A
    Cellular Technologies (Room 210A)
  • Monday, Feb 5th
    3:00 PM – 3:30 PM EST
    Immunocompetence at scale - Modeling the immune environment across a spectrum of disease pathologies
    Room/Location:  210A
    Cellular Technologies (Room 210A)
  • Monday, Feb 5th
    3:30 PM – 4:00 PM EST
    Utilization of translational models in drug discovery for rare diseases
    Room/Location:  210A
    Jason Ekert, PhD MBA – UCB Pharma
    Cellular Technologies (Room 210A)
  • Monday, Feb 5th
    4:00 PM – 4:30 PM EST
    A novel gut-on-chip model recreating physiological 3D peristalsis for disease modelling and efficacy testing
    Room/Location:  210A
    Nina D. Hobi, Dr. (he/him/his) – AlveoliX AG, Swiss Organs-on-Chip Innovation
    Cellular Technologies (Room 210A)Innovation Award
    Sponsored By 
  • Monday, Feb 5th
    4:30 PM – 5:00 PM EST
    Characterizing the health of transduced CAR-T cells using high-throughput image cytometry
    Room/Location:  210A
    Cellular Technologies (Room 210A)
  • Tuesday, Feb 6th
    10:00 AM – 12:00 PM EST
    Physiologically Relevant Models for Drug Discovery and Development
    Room/Location:  210A
    Cellular Technologies (Room 210A)
  • Tuesday, Feb 6th
    10:00 AM – 10:30 AM EST
    Novel human cell models in drug development: How 3D, Organoids & Organs on Chips can improve and renew current paths for pre-clinical & clinical phases
    Room/Location:  210A
    Adrian Roth – Hoffmann-La Roche
    Cellular Technologies (Room 210A)
  • Tuesday, Feb 6th
    10:30 AM – 11:00 AM EST
    Brain Micro(path)physiological Systems to model developing brain for drug and chemical testing
    Room/Location:  210A
    Lena Smirnova (she/her/hers) – Johns Hopkins University
    Cellular Technologies (Room 210A)
  • Tuesday, Feb 6th
    11:00 AM – 11:30 AM EST
    Donor to Donor Variability in Pharmacology: Mole Hill or Mountain?
    Room/Location:  210A
    Cellular Technologies (Room 210A)
  • Tuesday, Feb 6th
    11:30 AM – 12:00 PM EST
    A human Vagina Chip to study host-microbiome interactions in bacterial vaginosis for biotherapeutic development and validation
    Room/Location:  210A
    Abidemi Junaid, PhD – Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA
    Cellular Technologies (Room 210A)